S 1437
Drug-price Transparency in Communications (DTC) Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Drug-price Transparency in Communications (DTC) Act aims to require that direct-to-consumer advertisements for prescription drugs and biological products include clear and accurate pricing information. This bill codifies a previous rule by the Centers for Medicare & Medicaid Services (CMS) that mandated the inclusion of list prices for drugs in these advertisements. The legislation is driven by concerns about the significant cost of prescription drugs and the potential for misleading advertising to influence consumer choices and drive up prices.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Angus S., Jr. King
Lamar Alexander
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.